Skip to content
Home/Companies/Biotech/Dynal Biotech

Dynal Biotech

Biotech·Norway·Exited 2005·Held 4yr
Entry
2001
Hold
4yr
Exit
2005

Who owns Dynal Biotech?

Dynal Biotech is a Norwegian Biotech company, now owned by Invitrogen, which acquired it in 2005 from Nordic Capital.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Nordic Capital
Investor
Nordic Capital
Nordic Capital (early funds) · 1991 · Buyout

Key facts

HQNorway
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
Invitrogen
Exit Year
2005

More from Nordic Capital (early funds)

Other portfolio companies in the same fund.

Bufab
Exited 2014
IndustrialsSweden· 2005
Cloetta
Exited 2013
ConsumerSweden· 2005
FinnvedenBulten
3.0xExited 2011
MobilitySweden· 2005
Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.)
Exited 2012
PharmaUS· 2005
to Sandoz (Novartis)
Kompan
Exited 2014
ConsumerDenmark· 2005
to Christian Dyvig, PFA pension fund and KOMPAN management
Luvata
Exited 2014
IndustrialsFinland· 2005
to Mitsubishi Materials

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Dynal Biotech?

Dynal Biotech is now owned by Invitrogen, which acquired it in 2005 from Nordic Capital.

When did Invitrogen acquire Dynal Biotech?

Invitrogen acquired Dynal Biotech in 2005, buying from Nordic Capital.

Who did Dynal Biotech sell to?

Nordic Capital sold Dynal Biotech to Invitrogen in 2005 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue